Showing Latest Articles
Abbott's SIMCOR (niacin extended-release / simvastatin) Receives FDA Approval for New Dosage Strengths
Abbott, 07/29/2010
Abbott received U.S. Food and Drug Administration (FDA) approval for two new dosage strengths of SIMCOR, a cholesterol medication. The new SIMCOR dosage strengths combine 40 mg of simvastatin–the most commonly prescribed dose of simvastatin–with either 500 mg or 1,000 mg of niacin extended–release. SIMCOR is the first treatment to combine Abbott's proprietary niacin extended–release and simvastatin, the most commonly used statin.
